- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
836
Companies which are more than 50% undervalued based on analyst price target.
836 companies
Mural Oncology
Market Cap: US$45.3m
Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.
MURA
US$2.63
7D
3.5%
1Y
-29.9%
Recce Pharmaceuticals
Market Cap: AU$69.9m
Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.
RCE
AU$0.30
7D
1.7%
1Y
-53.8%
Quince Therapeutics
Market Cap: US$44.9m
A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
QNCX
US$1.02
7D
-6.4%
1Y
10.9%
Intervacc
Market Cap: SEK 436.2m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 1.28
7D
10.5%
1Y
-71.3%
Connect Biopharma Holdings
Market Cap: US$44.8m
A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases.
CNTB
US$0.81
7D
2.5%
1Y
-44.2%
Molecure
Market Cap: zł167.7m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.
MOC
zł8.30
7D
-2.4%
1Y
-46.5%
Neurizon Therapeutics
Market Cap: AU$68.9m
A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally.
NUZ
AU$0.14
7D
-3.6%
1Y
-22.9%
Oncolytics Biotech
Market Cap: CA$61.5m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
ONC
CA$0.71
7D
-2.7%
1Y
-55.6%
Prelude Therapeutics
Market Cap: US$44.1m
A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.
PRLD
US$0.78
7D
-4.9%
1Y
-79.4%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł163.2m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł35.00
7D
1.2%
1Y
-54.5%
Avalo Therapeutics
Market Cap: US$43.3m
A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.
AVTX
US$4.06
7D
-19.1%
1Y
-62.5%
Opus Genetics
Market Cap: US$43.1m
A clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases.
IRD
US$0.95
7D
-0.07%
1Y
-43.6%
Camp4 Therapeutics
Market Cap: US$42.9m
A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.
CAMP
US$2.13
7D
10.9%
1Y
n/a
Lantern Pharma
Market Cap: US$42.9m
Focuses on the discovery and development of oncology drug.
LTRN
US$3.98
7D
8.4%
1Y
-34.6%
Anebulo Pharmaceuticals
Market Cap: US$42.7m
A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.
ANEB
US$1.04
7D
-9.6%
1Y
-56.8%
Atara Biotherapeutics
Market Cap: US$42.6m
Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.
ATRA
US$7.27
7D
0.3%
1Y
-47.7%
OS Therapies
Market Cap: US$42.2m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.95
7D
-11.4%
1Y
n/a
Forte Biosciences
Market Cap: US$42.0m
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$6.38
7D
-4.2%
1Y
-64.1%
Rani Therapeutics Holdings
Market Cap: US$42.0m
Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
RANI
US$0.73
7D
-32.4%
1Y
-88.1%
Cantargia
Market Cap: SEK 405.2m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.63
7D
1.4%
1Y
-55.3%
Immuneering
Market Cap: US$40.9m
A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.
IMRX
US$1.14
7D
-8.8%
1Y
-28.3%
Sirnaomics
Market Cap: HK$318.2m
An RNA therapeutics biopharmaceutical company, discovers and develops product candidates for indications with medical needs.
2257
HK$2.94
7D
-3.0%
1Y
-59.5%
Verrica Pharmaceuticals
Market Cap: US$40.7m
A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.
VRCA
US$0.44
7D
-1.3%
1Y
-95.4%
Mersana Therapeutics
Market Cap: US$39.7m
A clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs.
MRSN
US$0.32
7D
-12.6%
1Y
-87.8%
IRLAB Therapeutics
Market Cap: SEK 378.1m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 7.29
7D
4.9%
1Y
-53.3%
RenovoRx
Market Cap: US$38.7m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.06
7D
2.9%
1Y
-24.8%
Rein Therapeutics
Market Cap: US$38.7m
A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.
RNTX
US$1.76
7D
-2.2%
1Y
-54.6%
Navamedic
Market Cap: NOK 397.4m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.50
7D
-3.0%
1Y
-32.6%
Reviva Pharmaceuticals Holdings
Market Cap: US$38.3m
A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.
RVPH
US$0.82
7D
-3.8%
1Y
-51.8%
Ascelia Pharma
Market Cap: SEK 370.5m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 3.86
7D
2.0%
1Y
-61.5%
ZYUS Life Sciences
Market Cap: CA$52.8m
Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.
ZYUS
CA$0.71
7D
-2.7%
1Y
-31.7%
Kidswell Bio
Market Cap: JP¥5.5b
Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.
4584
JP¥128.00
7D
1.6%
1Y
-8.6%
Grace Therapeutics
Market Cap: US$37.3m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.72
7D
-9.3%
1Y
-1.4%
Estrella Immunopharma
Market Cap: US$37.3m
A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
ESLA
US$1.03
7D
-8.8%
1Y
-3.7%
NurExone Biologic
Market Cap: CA$51.5m
Operates as a pharmaceutical technology company.
NRX
CA$0.66
7D
-2.9%
1Y
26.9%
MariMed
Market Cap: US$37.0m
Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.
MRMD
US$0.095
7D
-6.9%
1Y
-64.2%